Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy

Nat Med. 1998 Jul;4(7):794-801. doi: 10.1038/nm0798-794.

Abstract

We show that the fraction of proliferating CD4+ lymphocytes is similar in HIV-infected subjects in the early stage of disease and in HIV-negative subjects, whereas the fraction of proliferating CD8+ lymphocytes is increased 6.8-fold in HIV-infected subjects. After initiation of antiviral therapy, there is a late increase in proliferating CD4+ T cells associated with the restoration of CD4+ T-cell counts. These results provide strong support for the idea of limited CD4+ T-cell renewal in the early stage of HIV infection and indicate that after effective suppression of virus replication, the mechanisms of CD4+ T-cell production are still functional in early HIV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-HIV Agents / therapeutic use*
  • CD4-CD8 Ratio
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / immunology
  • Carbamates
  • Cell Division
  • Dideoxynucleosides / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Furans
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Ki-67 Antigen / metabolism
  • Lymph Nodes / metabolism
  • Male
  • Middle Aged
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Anti-HIV Agents
  • Carbamates
  • Dideoxynucleosides
  • Furans
  • HIV Protease Inhibitors
  • Ki-67 Antigen
  • Reverse Transcriptase Inhibitors
  • Sulfonamides
  • amprenavir
  • abacavir